Schedule 13G ownership disclosure
INVIVO THERAPEUTICS HOLDINGS CORP.
Security class unavailable · CUSIP: 46186M506
Event date: 2023-04-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 330,000
- Percent of class
- 11.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-23-001868
- Form type
- SC 13G
- Filer
- Foose Brice
- CIK
- CIK 1974830
- Filed
- Apr 25, 2023
- Reporting period
- Apr 20, 2023
- Description
- Schedule 13G beneficial ownership